Previous 10 | Next 10 |
home / stock / biov:cc / biov:cc news
BioVaxys Announces Successful Test-Run Production of its Bi-Haptenized Ovarian Cancer Vaccine Canada NewsWire VANCOUVER, BC , Dec. 1, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") is pleased to announ...
BIOVAXYS CLOSES FIRST TRANCHE OF NON-BROKERED PRIVATE PLACEMENT Canada NewsWire VANCOUVER, BC , Nov. 28, 2022 /CNW/ -- BioVaxys Technology Corp. ( CSE: BIOV, FRA: 5LB, OTCQB: BVAXF) ( "BioVaxys" or the "Company") announces that it has closed ...
BioVaxys Sarbecovirus Vaccine Interim Data Excellent Emerging Safety & Tolerability Profile with BVX-1021 BioVaxys Sarbecovirus Vaccine Interim Data Excellent Emerging Safety & Tolerability Profile with BVX-1021 Canada NewsWire VANCOUVER, BC , Nov...
BIOVAXYS ANNOUNCES COMPLETED PRIVATE PLACEMENT AND DEBT SETTLEMENT Canada NewsWire VANCOUVER, BC , Nov. 10, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ( "BioVaxys" or the "Company") announces that it has completed...
VANCOUVER, BC / ACCESSWIRE / October 6, 2022 / The Power Play by The Market Herald has announced the release of new interviews with RDARS, Infinity Stone Ventures, BioVaxys Technology, and Sitka Gold discussing their latest news. The Power Play by The Market Herald provides investors with a...
BIOVAXYS ANNOUNCES DEBT SETTLEMENT Canada NewsWire VANCOUVER, BC , Oct. 6, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ( "BioVaxys" or the "Company") announces that it has agreed to settle an aggregate of $300,...
Palm Beach, FL – October 6, 2022 – FinancialNewsMedia.com News Commentary – The global Cervical Cancer Treatment market has been expanding for several years and is projected to continue at a growing CAGR. Cervical Cancer is a cancer arising from the cervix w...
BioVaxys Executes Binding Term Sheet for the US Marketing & Distribution for Papilocare Gel and Oral Immunocaps BioVaxys Executes Binding Term Sheet for the US Marketing & Distribution for Papilocare Gel and Oral Immunocaps Canada NewsWire Agreement Include...
VANCOUVER, BC / ACCESSWIRE / September 28, 2022 / The Power Play by The Market Herald has announced the release of a new interview with BioVaxys Technology discussing their latest news. The Power Play by The Market Herald provides investors with a quick snapshot of what they need to know ab...
BioVaxys Further Expands Vaccines Intellectual Property Portfolio Canada NewsWire VANCOUVER, BC , Sept. 28, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announced today that in an action that...
News, Short Squeeze, Breakout and More Instantly...
Biovaxys Technology Corp. Company Name:
BIOV:CC Stock Symbol:
CNQC Market:
Biovaxys Technology Corp. Website:
Brittany Davison, CPA, CA, Joins BioVaxys as Business Advisor Canada NewsWire VANCOUVER, BC , July 18, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is pleased to announce that it has engaged Brittany Davison , ...
BIOVAXYS AND SPAYVAC-FOR-WILDLIFE, INC. ANNOUNCE LAUNCH OF TRIAL TO TEST IMMUNOCONTRACEPTION IN ASIAN ELEPHANTS Canada NewsWire VANCOUVER, BC and MADISON, Wis. , July 17, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys...
BioVaxys Technology Corp. Announces Failure to File Cease Trade Order PR Newswire VANCOUVER, BC , May 16, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the " Company ") announces that the Ontario Securities Commission (...